Floatz logo

Therapeutic Asset Ratings

178 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Theprubicin
Adjuvant Therapy
Zhejiang UniversityP2CCC (53)
Venetoclax
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang UniversityP2CCC (53)
Recombinant Interleukin-12
Advanced Pancreatic Cancer
Zhejiang UniversityP1/2CCC (53)
cd5-targeted car-t cells
T-Acute Lymphoblastic Leukemia
Zhejiang UniversityP1CCC (50)
NKG2D CAR-NK
Refractory Metastatic Colorectal Cancer
Zhejiang UniversityP1CCC (50)
Cyclophosphamide
Nasopharyngeal Carcinoma
Zhejiang UniversityP1/2CCC (50)
Fludarabine
Nasopharyngeal Carcinoma
Zhejiang UniversityP1/2CCC (50)
Anti-Cd33 Car T-Cells
Acute Myeloid Leukemia
Zhejiang UniversityP1/2CCC (49)
Fludarabine
Gray Zone Lymphoma
Zhejiang UniversityP1CCC (48)
pd1-psma-cart cells
Castrate-Resistant Prostate Cancer
Zhejiang UniversityP1CC (47)
Fulzerasib
Colorectal Cancer
Zhejiang UniversityP2CC (46)
Thiscart19A
B-ALL
Zhejiang UniversityP1CC (46)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang UniversityP1/2CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Pancreatic Cancer Metastatic
Zhejiang UniversityP1/2CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Pancreatic Cancer Resectable
Zhejiang UniversityP1/2CC (45)
Ineo-Vac-P01
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang UniversityP1/2CC (45)
Ineo-Vac-R01
Pancreatic Cancer Metastatic
Zhejiang UniversityP1/2CC (45)
Ineo-Vac-R01
Pancreatic Cancer Resectable
Zhejiang UniversityP1/2CC (45)
Ineo-Vac-T01
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang UniversityP1/2CC (45)
Ineo-Vac-T01 Personalized T Cell
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang UniversityP1/2CC (45)
Recombinant Human Il12/15-Pdl1B Oncolytic Hsv-1 )
Advanced Pancreatic Cancer
Zhejiang UniversityP1/2CC (45)
Anti-Cd70-Car-T Cells
Cervix Cancer
Zhejiang UniversityP1CC (43)
Anti-Cd70-Car-T Cells
Metastatic Tumor
Zhejiang UniversityP1CC (43)
Anti-Mesothelin Car-T Cells
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang UniversityP1CC (43)
cht101
Cervix Cancer
Zhejiang UniversityP1CC (43)
Showing 51 to 75 of 178 assets
PreviousPage 3 of 8Next